-
Mashup Score: 6Leyla Shune, MD, Discusses the Clinical Significance of Ide-Cel Data From ASH 2023 | Blood Cancers Today - 1 year(s) ago
Leyla Shune, MD, discusses the import of promising data for ide-cel in multiple myeloma presented at the 2023 ASH Annual Meeting & Exposition.
Tweet
Blood Cancers Today
Oncology / HematologyBlood Cancers Today is a property that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.
-
Mashup Score: 8The Future of Bone Marrow Tissue Analysis in Hematologic Diseases | Blood Cancers Today - 1 year(s) ago
Sanjay Patel, MD, discussed a study on spatial mapping of human hematopoiesis using bone marrow tissue.
Tweet
-
Mashup Score: 0What Is the Risk of COVID-19 in Patients with CLL? - 1 year(s) ago
Read the full article here
Tweet
Dr. Leyla Shune (@leshune) stopped by Blood Cancers Today to discuss the clinical significance of ide-cel data from #ASH23. "We are excited at the prospect of providing CAR-T earlier to our patients after two to three lines," she said. Watch here: https://t.co/kQyurTokPY https://t.co/xqy0UuCVNw